Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 65

Comparing low-dose buccal buprenorphine to standard opioids for pain relief and abuse potential

Official title: Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia

Run by Vanderbilt University Medical Center · NCT05988710 · Data updated 2026-11-12

This study is testing if a low-dose form of buprenorphine can relieve pain and has less potential for abuse compared to the standard opioid oxycodone, using healthy volunteers.

More Analgesia trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment120 (estimated)
SponsorVanderbilt University Medical Center
Academic / other
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedOctober 19, 2023
Main results expectedJanuary 2028
Study endsFebruary 2028
Registry record updatedJanuary 12, 2026
Trial IDNCT05988710 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults aged 18-65 who have not used opioids in the past three months.

Probably not a fit

Patients with chronic pain, current or prior substance use disorders, or certain medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the abuse potential and analgesic effects of low-dose buccal buprenorphine compared to a commonly used opioid, oxycodone, in a controlled setting. It will involve 60 healthy participants who will undergo a within-subjects crossover design, receiving different doses of buprenorphine, placebo, and oxycodone across multiple sessions. Participants will be assessed for pain responsiveness and drug liking metrics to determine the relative safety and efficacy of buprenorphine as an alternative to traditional opioids.

Why it matters

Potential benefit: If successful, this study could provide a safer alternative to traditional opioids for pain management with a lower risk of abuse.

How similar studies have gone: Other studies have explored the safety and efficacy of buprenorphine, but this specific approach comparing low-dose buccal buprenorphine to oxycodone is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Intact cognitive status and ability to provide informed consent
* Ability to read and write in English sufficiently to understand and complete study questionnaires
* Age 18-65
* Opioid-naive status (defined as no use of full mu-opioid receptor (MOR) agonist, partial MOR agonist, or mixed agonist/antagonist medications for the prior 3 months by patient report

Exclusion Criteria:

* Liver/kidney disease
* Chronic pain
* Current/prior substance use disorder
* Pregnancy (to avoid fetal drug exposure, with pregnancy tests conducted to confirm eligibility)
* Seizure disorder
* Certain psychiatric conditions (severe depression, bipolar disorder, psychotic disorders)
* Recent use of medications that may interfere with study drug metabolism
* Recent benzodiazepine or opioid use (confirmed via rapid urine screening prior to each lab session)
* The presence of any medical conditions felt by the study physician to render participant unsafe
* Prior allergic reaction or intolerance to oxycodone, buprenorphine, or their analogs (explicitly including moderate-to-severe nausea or vomiting with prior opioids)
* Recent use of marijuana, delta-8 THC, CBD, and similar products
* Recent use of kratom
* Severe asthma
* Long QT syndrome
* Parkinson disease
* Weight \<60 kg

Where it's running

  • Vanderbilt University Medical Center
    Nashville, Tennessee, United States
    Recruiting

Study contacts

  • Principal investigator: Daniel Larach, MD, MSTR, MA — Vanderbilt University Medical Center
  • Study coordinator: Daniel Larach, MD, MSTR, MA
  • Email: daniel.larach@vumc.org
  • Phone: 615-322-6033

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.